InvestorsHub Logo
Followers 22
Posts 960
Boards Moderated 0
Alias Born 10/17/2007

Re: bbhuey post# 415

Friday, 05/21/2021 11:54:23 AM

Friday, May 21, 2021 11:54:23 AM

Post# of 428
PRTG owns approximately 10%. Intensity Therapeutics is involved in two studies now. Phase 2 with Merck and Bristol Meyers. Phase 2 in Canada at the Ottawa Hospital. Here is the clinical study page for Intensity.

https://intensitytherapeutics.com/clinical-research/

I've been in this for quite awhile. Looks exciting over the next 30-90 days. Portage Biotech has a tremendous pipeline of drugs and the CEO and Management Team are mostly all ex-big pharma specialists. Ian Walters, the CEO is particularly worth doing some DD on.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRTG News